Prism Medico & Pharmacy News

Prism Medico Board Approves Rs. 25 Crore Equity Issue

Prism Medico and Pharmacy Limited board approved issuance of 75 lakh equity shares and 50 lakh convertible warrants at Rs. 20 each, raising Rs. 25 crore through preferential allotment.

Prism Medico and Pharmacy Limited Reports Strong Quarterly Performance with 65.73 Lakh Net Profit

Prism Medico and Pharmacy Limited's Board of Directors approved unaudited standalone financial results for the quarter ended June 30, 2025. The company reported revenue from operations of 158.87 lakhs, a significant increase from 7.28 lakhs in the previous quarter and 6.27 lakhs in the corresponding quarter last year. Net profit for the quarter reached 65.73 lakhs, compared to 4.15 lakhs in the previous quarter and a loss of 9.00 lakhs in the year-ago period. Total expenses were 93.84 lakhs, with cost of materials consumed being the largest component at 85.75 lakhs. The company's earnings per share improved to 0.0108 rupees from 0.0007 rupees in the previous quarter. The paid-up equity share capital remained stable at 606.34 lakhs. The results were reviewed by auditors Garg Mendiratta & Associates and approved by the Board at a meeting held on August 14, 2025.